Host- and tumour-related prognostic factors associated with disease-free survival on univariate analysis
| Factor | No. of patients | Disease-free survival rate, % | p value | ||
|---|---|---|---|---|---|
| 1 yr | 3 yr | 5 yr | |||
| Age, yr | 0.05 | ||||
| < 50 | 186 | 68.3 | 49.8 | 41.2 | |
| ≥ 50 | 285 | 62.5 | 38.9 | 32.5 | |
| Preoperative albumin level, g/L | 0.02 | ||||
| < 35 | 37 | 54.1 | 23.8 | 20.8 | |
| ≥ 35 | 434 | 65.7 | 45.1 | 37.2 | |
| Postoperative splenic volume increase, % | 0.0 | ||||
| < 19.0 | 275 | 69.5 | 48.0 | 40.3 | |
| ≥ 19.0 | 196 | 58.1 | 36.5 | 29.8 | |
| Microvascular invasion | < 0.001 | ||||
| Present | 179 | 53.1 | 32.4 | 27.4 | |
| Absent | 292 | 71.9 | 49.5 | 41.2 | |
| BCLC stage | < 0.001 | ||||
| 0 | 69 | 84.0 | 60.4 | 48.7 | |
| A | 165 | 71.5 | 48.4 | 38.6 | |
| B | 237 | 54.0 | 34.2 | 30.4 | |
BCLC = Barcelona Clinic Liver Cancer.